Source:http://linkedlifedata.com/resource/pubmed/id/10886508
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-8-15
|
pubmed:abstractText |
Several phenotypes of antigen-presenting cells are present in the dermis, where they presumably function to present encountered antigens for immune responses. This study examined the ability of dermal antigen-presenting cells to present tumor-associated antigens for the induction of in vivo antitumor immunity. Total murine dermal cells were exposed either to medium alone or to medium containing tumor-associated antigens from S1509a tumor cells. Subsequently, dermal cells were injected subcutaneously at weekly intervals into naïve mice for a total of three immunizations. One week following the final immunization, mice were challenged with living tumor cells. In these experiments, dermal cells pulsed with tumor-associated antigens induced protective immunity to tumor growth. Dermal cells exposed to tumor-associated antigens were also able to elicit delayed-type hypersensitivity after footpad injection into mice previously immunized against S1509a tumor cells. The ability to present tumor-associated antigens for both induction of antitumor immunity and elicitation of delayed-type hypersensitivity was dependent on I-A+ cells and was genetically restricted. Finally, dermal cells tended towards eliciting a greater antitumor delayed-type hypersensitivity response than epidermal cells. These results show that the murine dermis contains antigen-presenting cells capable of processing S1509a tumor antigens for the generation of protective antitumor immunity in vivo.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-202X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
115
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-61
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10886508-Animals,
pubmed-meshheading:10886508-Antibodies, Monoclonal,
pubmed-meshheading:10886508-Antigen-Presenting Cells,
pubmed-meshheading:10886508-Antigens, Neoplasm,
pubmed-meshheading:10886508-Cancer Vaccines,
pubmed-meshheading:10886508-Dendritic Cells,
pubmed-meshheading:10886508-Female,
pubmed-meshheading:10886508-Hypersensitivity, Delayed,
pubmed-meshheading:10886508-Mice,
pubmed-meshheading:10886508-Mice, Inbred BALB C,
pubmed-meshheading:10886508-Skin,
pubmed-meshheading:10886508-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Tumor antigen presentation by dermal antigen-presenting cells.
|
pubmed:affiliation |
Department of Dermatology, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York 10021, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|